![hero image](/_next/image?url=%2Fimages%2FCRLogo.png&w=384&q=75)
Text Registration
Copyright Title
98812 Chronic Obstructive Pulmonary Disease (COPD)
Status
Published
on 3 Dec 2019
Year of Creation
2019
Copyright Claimant
CE Resource, Inc., dba NetCE
Registration Number
TX0008861965
on 3 Dec 2019Copyright Summary
The U.S. Copyright record (Registration Number: TX0008861965) dated 3 Dec 2019, pertains to an electronic file (eService) titled "98812 Chronic Obstructive Pulmonary Disease (COPD)" created in 2019. The copyright holder is CE Resource, Inc., dba NetCE, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to CE Resource, Inc., dba NetCE.
Application Details
Registration Number
TX0008861965
Registration Date
12/3/2019
Year of Creation
2019
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
CE Resource, Inc., dba NetCE CE Resource, Inc NetCE
Physical Description
Print material
First Publication Nation
United States
Notes
Local Copyright Note: C.O. correspondence
Statements
Application Title Statement: 98812 Chronic Obstructive Pulmonary Disease (COPD)
Author Statement: CE Resource, Inc., dba NetCE N/A-N/A employer for hire Domicile: United States Authorship: text
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.